Astrazeneca AZN
NYSE AZN
$172.60 +4.17 (+2.48%)
At close: Oct 22, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Liabilities from Discontinued Operations (2011)

Updated

Astrazeneca (AZN) recorded Liabilities from Discontinued Operations of $2.3 billion in Q4 2020, up 7.0% from $2.15 billion a year earlier.

Analysis

Astrazeneca (AZN) Liabilities from Discontinued Operations (2011) Analysis & Trends

Starting with Q2 2011, Astrazeneca's Liabilities from Discontinued Operations history includes 4 quarters.

  • Across earlier years, Liabilities from Discontinued Operations came in at $2.15 billion in FY2019 (+16.8%) and $1.84 billion in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Vertex Pharmaceuticals 135.58 Bn 107.59 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 -196.00 Mn
API Access

Astrazeneca Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=AZN&period=max&api_key=YOUR_API_KEY